Increasing documentation of eye exams for children with cystic fibrosis treated with modulators (NACFC 2026) - Sep 9, 2026 - Abstract #721; "Background: Non-congenital lens opacities have been described in pediatric patients taking Ivacaftor containing Cystic Fibrosis Transmembrane Conductance Regulator modulators... Having a systematic process allows for improvement in our documentation of eye exams. We were also able to identify barriers in completing the exam which allowed for further interventions to improve care."
Clinical • Cystic Fibrosis • Genetic Disorders • Immunology • Respiratory Diseases • CFTR
|
|
L. Burns 1; L. Vernon 2; S. Rebecca 3; H. Levy 4; E. Seffrood 3; C. Becker 5; J. Voller 6
|